BioSpace News Archive

Drug Development

Talaris Therapeutics, Inc. Announces Promising Phase 2 Data of Novel, Allogeneic Cell Therapy in Living Donor Kidney Transplant Recipients

FCR001 established durable immune tolerance in 70% of patients

April 18, 2019
·
4 min read
iAnthus Marks 4/20 Holiday with the Launch of Flower Sale in Florida, Deals and Events Throughout U.S. Dispensaries

iAnthus Capital Holdings, Inc. is pleased to announce that it is launching the sale of smokable flower and pre-rolled joints in Florida through iAnthus’ “GrowHealthy” Florida dispensary brand.

April 18, 2019
·
2 min read
FDA

Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration

New hematologic biomarker has the potential to revolutionize clinicians’ approach to sepsis triage and diagnosis

April 18, 2019
·
5 min read
Drug Development

Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer

Enrollment Sufficient to Support the Interim Efficacy Analysis

April 18, 2019
·
12 min read
Deals

Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019

Acorda Therapeutics, Inc. will host a conference call and webcast to report its first quarter 2019 update and financial results on Thursday, May 2 at 8:30 a.m. ET.

April 18, 2019
·
3 min read
FDA

Viela Bio Receives U.S. FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder

Designation based on positive primary analysis of pivotal study, N-MOmentum

April 18, 2019
·
4 min read
Business

Philip Morris International Inc. (PMI) Reports 2019 First-Quarter Reported Diluted EPS of $0.87 versus $1.00 in 2018, Reflecting Currency-Neutral Adjusted Diluted EPS Growth of 15.0%

Revises 2019 Full-Year Reported Diluted EPS Forecast to at Least $4.87 versus $5.08 in 2018, Reflecting Currency-Neutral Like-for-Like Adjusted Diluted EPS Growth of at Least 8%

April 18, 2019
·
44 min read
BioMidwest

SVIN Announces the Advanced Stroke Emergency Support EMS Course NOW AVAILABLE!

Society of Vascular and Interventional Neurology The Society of Vascular and Interventional Neurology releases the Advanced Stroke Emergency Support EMS training course.

April 18, 2019
·
2 min read
Pharm Country

Hemopure Plays A Pivotal Role In A Pioneering Study Published in Nature

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics), a world leader in oxygen-carrying solutions, today announces pioneering research conducted at Yale School of Medicine highlighting an innovative system that restores brain circulation and some cellular functions in pig brains four hours after death.

April 18, 2019
·
3 min read
Drug Development

Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965

Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF), today announced the first healthy volunteer has been dosed in a Phase 1 clinical trial of the company’s lead drug candidate IDL-2965.

April 18, 2019
·
2 min read